Towards Healthcare Research & Consulting
U.S. AI in Life Science Market
Updated Date: 01 June 2026   |   Report Code: 6917
[email protected] +1 804-441-9344
Download Sample Order Now

U.S. AI in Life Science Market Investment Opportunities in AI-Based Drug Discovery

U.S. AI in Life Science Market (By Component: Software, Hardware, Service; By Technology: Machine Learning, Natural Language Processing, Computer Vision, Context-Aware Computing, Predictive Analytics, Generative AI; By Application: Drug Discovery & Development, Precision Medicine, Medical Imaging & Diagnostics, Clinical Trial Management, Genomics, Research & Development, Supply Chain & Manufacturing; By Deployment Mode: Cloud-Based, On-Premises, Hybrid; By Enterprise Size: Large Enterprises, Small & Medium Enterprises; By Delivery Mode: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Hospitals & Healthcare Providers, Academic & Research Institutes, Medical Device Companies;) Country-level Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035.

Last Updated : 01 June 2026 Category: Life Sciences Insight Code: 6917 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • U.S. AI in Life Science Market Analysis, By Component
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Deployment Mode
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Enterprise Size
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. AI in Life Science Market Analysis, By Delivery Mode
    • Market Size, Forecast & CAGR, By Component, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Component
      • By Technology
      • By Application
      • By Deployment Mode
      • By Enterprise Size
      • By Delivery Mode
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Pfizer
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Sanofi
    • Novartis & Eli Lilly
    • AstraZeneca
    • Insilico Medicine

FAQ's

Answer : The U.S. AI in the life science market in 2026 is valued at USD 1.14 billion and is projected to climb to USD 5.91 billion by 2035, with a CAGR of 20.05% over the forecast period.

Answer : National Institutes of Health, FDA, WHO, CDC.
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar